Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E. Schindler, Zachary Hausle, Yan Li, Kellen K. Petersen, Jeffrey L. Dage, Lei Du-Cuny, Ziad S. Saad, Benjamin Saef, Gallen Triana-Baltzer, David L. Raunig, Janaky Coomaraswamy, Michael Baratta, Emily A. Meyers, Yulia Mordashova, Carrie E. Rubel, Kyle Ferber, Hartmuth Kolb, Nicholas J. Ashton, Henrik Zetterberg, Erin G. Rosenbaugh, Martin Sabandal, Leslie M. Shaw, Anthony W. Bannon, William Z. Potter, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team
doi: https://doi.org/10.1101/2024.10.25.24316144
Marta Milà-Alomà
1Northern California Institute for Research and Education, San Francisco, CA, USA 94141
2Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA 94143
Duygu Tosun
1Northern California Institute for Research and Education, San Francisco, CA, USA 94141
2Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA 94143
Suzanne E. Schindler
3Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA 63110
Zachary Hausle
1Northern California Institute for Research and Education, San Francisco, CA, USA 94141
2Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA 94143
Yan Li
3Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA 63110
Kellen K. Petersen
3Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA 63110
Jeffrey L. Dage
4Department of Neurology, Indiana University School of Medicine, 355 W 16th St Indianapolis, IN, USA 46202
5Stark Neurosciences Research Institute, Indiana University School of Medicine, NB Building, 320 W 15th St #414, Indianapolis, IN, USA 46202
Lei Du-Cuny
6AbbVie, Knollstraße 50, 67061, Ludwigshafen am Rhein, Rheinland-Pfalz, Germany
Ziad S. Saad
7Neuroscience Biomarkers, Johnson and Johnson Innovative Medicine, 3210 Merryfield Row, San Diego, CA, USA 20892
Benjamin Saef
3Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA 63110
Gallen Triana-Baltzer
7Neuroscience Biomarkers, Johnson and Johnson Innovative Medicine, 3210 Merryfield Row, San Diego, CA, USA 20892
David L. Raunig
8Takeda Pharmaceutical Company Ltd., 500 Kendall St., Cambridge, MA, USA 02142
Janaky Coomaraswamy
8Takeda Pharmaceutical Company Ltd., 500 Kendall St., Cambridge, MA, USA 02142
Michael Baratta
8Takeda Pharmaceutical Company Ltd., 500 Kendall St., Cambridge, MA, USA 02142
Emily A. Meyers
9Alzheimer’s Association, 225 N Michigan Ave., Chicago, IL, USA 60603
Yulia Mordashova
6AbbVie, Knollstraße 50, 67061, Ludwigshafen am Rhein, Rheinland-Pfalz, Germany
Carrie E. Rubel
10Biogen, 225 Binney St., Cambridge, MA, USA 02142
Kyle Ferber
10Biogen, 225 Binney St., Cambridge, MA, USA 02142
Hartmuth Kolb
11Enigma Biomedical Group, CA, USA
Nicholas J. Ashton
12Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Biskopsbogatan 27, S-431 80, Mölndal, Sweden
Henrik Zetterberg
12Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Biskopsbogatan 27, S-431 80, Mölndal, Sweden
13Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Biskopsbogatan 27, S-431 80, Mölndal, Sweden
14UK Dementia Research Institute Fluid Biomarkers Laboratory, UK DRI at UCL, 3rd Floor, Queen Square House, Queen Square, London WC1N 3BG, United Kingdom
15Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom
16Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Units 1501-1502, 1512-1518, 15/F Building 17W, 17 Science Park W Ave, Science Park, Hong Kong, China
17Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, 600 Highland Ave J5/1Mezzanine, Madison, WI, USA 53792
Erin G. Rosenbaugh
18The Foundation for the National Institutes of Health, 11400 Rockville Pike, Suite 600, North Bethesda, MD, USA 20852
Martin Sabandal
18The Foundation for the National Institutes of Health, 11400 Rockville Pike, Suite 600, North Bethesda, MD, USA 20852
Leslie M. Shaw
19Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, USA 19104
Anthony W. Bannon
20AbbVie, 1400 Sheridan Rd., North Chicago, IL, USA 60064
William Z. Potter
21Highly qualified expert
Article usage
Posted November 14, 2024.
Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E. Schindler, Zachary Hausle, Yan Li, Kellen K. Petersen, Jeffrey L. Dage, Lei Du-Cuny, Ziad S. Saad, Benjamin Saef, Gallen Triana-Baltzer, David L. Raunig, Janaky Coomaraswamy, Michael Baratta, Emily A. Meyers, Yulia Mordashova, Carrie E. Rubel, Kyle Ferber, Hartmuth Kolb, Nicholas J. Ashton, Henrik Zetterberg, Erin G. Rosenbaugh, Martin Sabandal, Leslie M. Shaw, Anthony W. Bannon, William Z. Potter, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team
medRxiv 2024.10.25.24316144; doi: https://doi.org/10.1101/2024.10.25.24316144
Timing of changes in Alzheimer’s disease plasma biomarkers as assessed by amyloid and tau PET clocks
Marta Milà-Alomà, Duygu Tosun, Suzanne E. Schindler, Zachary Hausle, Yan Li, Kellen K. Petersen, Jeffrey L. Dage, Lei Du-Cuny, Ziad S. Saad, Benjamin Saef, Gallen Triana-Baltzer, David L. Raunig, Janaky Coomaraswamy, Michael Baratta, Emily A. Meyers, Yulia Mordashova, Carrie E. Rubel, Kyle Ferber, Hartmuth Kolb, Nicholas J. Ashton, Henrik Zetterberg, Erin G. Rosenbaugh, Martin Sabandal, Leslie M. Shaw, Anthony W. Bannon, William Z. Potter, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ and Phosphorylated Tau as Predictors of Amyloid and Tau Positivity in Alzheimer’s Disease Project Team
medRxiv 2024.10.25.24316144; doi: https://doi.org/10.1101/2024.10.25.24316144
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)